𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Further evidence for the molecular heterogeneity of chronic myeloid leukemia

✍ Scribed by A. Hernandez; L. Corral; A. Muñiz; C. Alaez; E. Espinosa; G. Martinez; P. Hernandez


Book ID
105291680
Publisher
Springer
Year
1991
Tongue
English
Weight
636 KB
Volume
62
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Acute myeloid leukemia developing during
✍ Attaphol Pawarode; Sheila N.J. Sait; Alain Nganga; Lionel J. Coignet; Maurice Ba 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 171 KB

The BCR/ABL tyrosine kinase inhibitor imatinib mesylate produces a high rate of cytogenetic responses in patients with Philadelphia (Ph)-positive chronic myeloid leukemia (CML), but secondary clonal chromosome abnormalities may develop in Ph-negative cells, and acute myeloid leukemia (AML) has been